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Electronic letter
Novel mutations of SOX10 suggest a dominant
negative role in Waardenburg-Shah syndrome
Mai Har Sham, Vincent Chi Hang Lui, Benedict Ling Sze Chen, Ming Fu,
Paul Kwong Hang Tam
EDITOR—Waardenburg syndrome (OMIM
193500) is a rare disorder (1 in 40 000 live
births) characterised by distinctive facial fea-
tures, pigmentary disturbance (white forelock,
heterochromia iridis, white eyelashes, leuco-
derma), and cochlear deafness.1 Waardenburg-
Shah syndrome combines the features of
Waardenburg syndrome and Hirschsprung’s
disease (also called Waardenburg-Hirschsprung
disease, Waardenburg syndrome type IV, WS4)
(OMIM 277580). In addition to having white
forelock, eyebrows, and eyelashes, the patients
present in the neonatal period with intestinal
obstruction, characteristic of Hirschsprung’s
disease.2–4 Mutations in three diVerent genes
have been identified in WS4 patients. These
genes include the endothelin-B receptor gene
(EDNRB),5 the gene for its ligand endothelin-3
(EDN3),6 7 and the SOX10 gene. It has been
observed that heterozygous mutations of
EDNRB or EDN3 are found in Hirschsprung’s
disease alone8–12 and only homozygous muta-
tions of either gene are found in WS4.
Therefore, when resulting from EDN3 or
EDNRB mutations, WS4 is inherited as an
autosomal recessive trait.
Among the WS4 patients studied so far, 10
out of 37 have been reported to have had
SOX10 mutations.13–16 Interestingly, when
SOX10 mutations are involved, WS4 is inher-
ited as an autosomal dominant condition. The
presence of SOX10 mutations in the
Waardenburg-Shah patients suggest that the
SOX10 gene could be involved in regulatory
and signalling pathways for the normal devel-
opment of the neural crest cell lineages which
diVerentiate into melanocytes and enteric gan-
glia. The involvement of Sox10 in the develop-
ment of enteric neurones has also been
reported in the Dom (Dominant megacolon)
mouse model of Hirschsprung’s disease. It was
shown that a single base insertion in the mouse
Sox10 gene was responsible for the megacolon
phenotype of the Dom mutant.17 18 Interest-
ingly, in the Waardenburg-Shah patients as well
as the Dom mutant mouse model, the intestinal
aganglionosis phenotype appears to originate
from heterozygous SOX10/Sox10 mutations,
suggesting that the phenotype could be the
result of haploinsuYciency.
In this study, we examined mutations in
three WS4 patients, two of Chinese origin and
one English. We identified two novel SOX10
mutations among three WS4 patients we inves-
tigated. We also reviewed all the SOX10 muta-
tions reported so far to correlate SOX10 muta-
tions with the aganglionosis phenotype
observed in the patients.
Patients
Patient 1 is a Chinese girl, born at term, who
was admitted to hospital because of failure of
passage of meconium within the first 24 hours
of life, followed by vomiting and a distended
abdomen. She has bilateral hearing loss, light
brown hair, and vivid blue irides with grey
speckles. The diagnosis of Hirschsprung’s dis-
ease was made on the basis of history, physical
findings, and barium enema results, and was
confirmed by the pathological findings of the
resected specimen. At operation, the agangli-
onic segment was found to involve the distal
sigmoid colon and rectum. A pull through pro-
cedure was performed. There is no family his-
tory.
Patient 2 is a Chinese boy, born at term, who
developed abdominal distension and vomiting
on day 2 of life with delayed passage of meco-
nium. He had dysmorphic facial features with
ptosis of the right eye. He is profoundly deaf
and suVers from mental and global develop-
mental retardation. He has blue eyes on both
sides and one strand of white hair over the
forehead. All these are features of Waardenburg
syndrome. On laparotomy, frozen section
histology of intestinal biopsies showed total
colonic aganglionosis and ileostomy was per-
formed. Subsequently, total colostomy and
Duhamel pull through was performed. There is
no family history.
Patient 3 is an English boy, born at term,
who presented with failure of passage of meco-
nium, bile stained vomiting, and a distended
abdomen on day 1. Rectal biopsy confirmed
the diagnosis of Hirschsprung’s disease. He
had rectosigmoid aganglionosis. Temporary
colostomy was performed initially and defini-
tive pull through operation done subsequently.
The presence of a white forelock and deafness
led to the diagnosis of Waardenburg syndrome.
There is no family history.
Methods
DNA was extracted from peripheral blood
samples collected from patients and their fam-
ily members using QiaAmp Blood Kit (Qiagen)
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or by phenol chloroform extraction method.
Six sets of primers (sequences summarised in
table 1) were used to amplify SOX10 gene
fragments covering exons 2 to 5 and intron-
exon junctions by PCR. The PCR products
were purified and the DNA sequences deter-
mined by an automated sequencer (ABI Prism
310) after cycle sequencing reactions (dRhod-
amine kit). All sequences were determined
from both forward and reverse orientations
(table 1). Mutations were confirmed by
sequencing duplicate PCR templates from
separate reactions.
Results
Two diVerent novel SOX10 mutations were
identified in the two Chinese WS4 patients.
Patient 1 was diagnosed as having typical short
segment HSCR; her intestinal aganglionosis
extended to the rectosigmoid region. Sequence
analysis showed that she had a heterozygous
frameshift mutation in exon 3 of the SOX10
gene and a single nucleotide (G) at nucleotide
position 168 from the start codon is deleted (fig
1B). This mutation would lead to a frameshift
in the mutant protein producing a truncated
SOX10 protein of 107 amino acids (fig 1E).
This truncated mutant protein, which lacks the
HMG DNA binding and the C-terminal trans-
activating domains, is likely to be non-
functional. No SOX10 mutation could be
detected in her parents, indicating that the
168delG mutation in patient 1 was sporadic.
Patient 2 was diagnosed as having total
colonic aganglionosis. Analysis of the SOX10
sequence showed that he had a heterozygous
mutation at the stop codon in exon 5. A trans-
version of T to A (fig 1D) at the first base of the
stop codon changed it to a codon for lysine.
The mutant SOX10 open reading frame
encodes an extra 86 amino acid long proline
rich peptide at the C-terminus (fig 1E). Exam-
ination of the SOX10 sequence of his parents
Table 1 Sequences of PCR primers for amplification of SOX10 genomic fragments
covering the entire coding region and intervening exon-intron junctions
Exon Primer sequence Product size (bp)
2 forward 5'GCC TGG AGG CTC CAC CTT CTG C-3' 443
reverse 5'-TCC CTC AGC CTG CCC CAA CG-3'
3 forward 5'-GGC TGT GCC CAC GTC CTG TCT C-3' 689
reverse 5'-CAG TCC CGC TCT GAG GTG CAG G-3'
4 forward 5'-AGT CCA CAA ATC ATA GGG CAC A-3' 527
reverse 5'-TAG AGT CCA GGG TCT CAT TGC C-3'
5a forward 5'-CAT GCT GCC AAA ATG TGA AAC T-3' 661
reverse 5'-ATG GTC AGA GTA GTC AAA CTG G-3'
5b forward 5'-CAG ATC GCC TAC ACC TCC CTC A-3' 696
reverse 5'-GGG CAT GTC AGA CCC TCA CTA T-3'
5c forward 5'-ACC ACT CCT ATG ACT CCT GTT T-3' 749
reverse 5'-AGA GGG GAC TAC TGA GAT AAA T-3'
Figure 1 Analysis of SOX10 mutations in WS4 patients. DNA sequence analysis of (A) normal exon 3 and (B) exon 3 of patient 1 shows that there is a
deletion of a G residue at nucleotide position 168 (open arrowhead). Analysis of (C) normal exon 5 and (D) exon 5 of patient 2 shows a T→A
transversion at the first base of the stop codon (filled arrowhead), changing it into a codon for lysine. (E) A diagram illustrating the sequences for the
mutant SOX10 peptide encoded by the frameshift mutation 168delG from patient 1 and the proline rich C-terminal peptide encoded by the X467K
mutation from patient 2. The normal functional domains of the SOX10 protein and all reported SOX10 mutations in WS4 patients are also summarised
here, illustrating that mutations around the HMG domain all led to hypoganglionosis or short segment aganglionosis, and mutations in the transactivation
domain all led to long segment or total aganglionosis.
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confirmed that the X467K mutation in patient
2 was also sporadic.
Patient 3 has typical features of
Waardenburg-Shah syndrome and rectosig-
moid aganglionosis. Our mutation analysis on
the SOX10 gene showed no nucleotide change
in the entire coding region and in the
intron-exon junctions.
Discussion
The mutation identified in patient 1 (168delG)
would lead to the production of a truncated
protein lacking the DNA binding and the
putative transactivation domains (fig 1E). It is
likely that the small polypeptide produced from
the mutant allele is non-functional. Moreover,
the mutant mRNA produced from this mutant
allele might be unstable and easily degraded
within the cell.19 Therefore, if the 168delG
allele was malfunctional, the phenotype dis-
played by patient 1 would result from a hetero-
zygous null mutation. This would support the
hypothesis that Waardenburg-Shah syndrome
is the result of haploinsuYciency of a func-
tional SOX10 allele.
The other novel mutation we identified
(X467K), which aVected the stop codon of
SOX10, would produce a larger protein with an
extra C-terminal proline rich domain of 86
amino acids long (fig 1E). Interestingly, a
mutation which would produce a similar but
shorter mutant protein has been identified in a
patient with complex syndromes in addition to
WS4; in that case a 12 bp deletion at the stop
codon led to the production of an extra 82
amino acid domain.15 It has been postulated
that the C-terminal proline rich domain of this
mutant SOX10 protein has a dominant nega-
tive eVect. In terms of phenotype of the colon,
both patients who have similar mutations
(patient 2 in this study and that described by
Inoue et al15) have more severe intestinal agan-
glionosis (total colonic aganglionosis and long
segment aganglionosis). However, patient 2 in
this study does not have the dysmyelinating
features and the other complex syndromes
described by Inoue et al.15 Whether the
C-terminal proline rich domain contributed to
a more severe intestinal aganglionosis in the
patients would require further experimental
support, possibly in an animal model.
Among the WS4 patients studied so far
(including this study), 12 out of 40 have been
identified to have SOX10 mutations.13–16
Waardenburg-Shah syndrome is a rare malfor-
mation, yet mutations in the three known
causative genes (EDN3,EDNRB,SOX10) have
so far only explained some of the patients. On
the other hand, SOX10 mutation per se might
not be suYcient to cause WS4. A SOX10 mis-
sense mutation (S135T) has been reported in a
case of Yemenite deaf-blind hypopigmentation
syndrome.20 The patient described had charac-
teristics of hypopigmentation, but not all the
features of Waardenburg syndrome nor intesti-
nal aganglionosis. In another case, a single
nucleotide deletion (795delG) in the SOX10
gene has been reported in a patient with
peripheral neuropathy, hypomyelination, deaf-
ness, and chronic intestinal pseudo-
obstruction, which are not features of WS4.21
WS4 patients who have SOX10 mutations also
displayed diVerent severity in the extent of
intestinal aganglionosis. Table 2 summarises
the 12 cases of WS4 patients with SOX10
mutations reported so far and their associated
intestinal phenotype. Generally, there seems to
be a correlation between the specific location of
the mutation in the SOX10 sequence and the
severity of intestinal aganglionosis (fig 1E).
The reported mutations can be grouped into
four categories. (1) Mutations that lead to a
truncation of SOX10 protein before the HMG
domain (Y83X, 168delG), or that aVect the
HMG domain directly (482ins6), are function-
ally equivalent to null mutations, as the mutant
proteins would not have any DNA binding
activity. These mutations tend to be correlated
with a milder phenotype, that is, hypoganglio-
nosis or short segment HSCR. (2) Mutations
that lead to a truncation of SOX10 protein
shortly after the HMG domain (E189X,
Y207X) would produce a mutant protein that
potentially would have DNA binding activity
but would lack the other functional domains.
These mutations have also been shown to
cause milder short segment HSCR. (3) Muta-
tions which aVect the C-terminal putative
transactivation domain (Q377X, 1400del12,
X467K) tend to have a stronger eVect, leading
to long segment or total aganglionosis. (4) The
other mutations which cause truncation of the
SOX10 protein in between the HMG domain
and the C-terminal domain (S251X, Y313X)
have more variable phenotypic consequences.
In particular, the Y313X mutation detected in
two diVerent families actually led to a diVerent
intestinal phenotype.16 A region between the
Table 2 Summary of SOX10 mutations identified and phenotypes of aVected patients
Sex SOX10 mutation EVect on protein sequence AVected colon phenotype Reference
F nt168delG Frameshift→truncation before HMG Short segment HSCR This study (patient 1)
M Y83X (C→A at nt249) Truncation before HMG domain Hypoganglionosis* 14 (family 2)
NA nt482ins6 Duplication of LR in HMG domain Short segment HSCR 14 (family 3)
NA E189X (G→T at nt565) Truncation after HMG domain Short segment HSCR 14 (family 1)
M Y207X Truncation after HMG domain Short segment HSCR 13 (family 140)
M S251X (C→A at nt752) Truncation after HMG domain Total colonic aganglionosis 16 (family 3)
M Y313X (C→A at nt939) Truncation after HMG domain Short segment HSCR 16 (family 2)
M Y313X (C→A at nt939) Truncation after HMG domain Total colonic aganglionosis 16 (family 1)
M nt1076delGA Frameshift→37aa added at 359 NA 14 (family 4)
M Q377X Truncation of C-terminal domain Variable diagnosis, ranging from
hypoganglionosis to long segment HSCR
13 (family 192)
F nt1400del12 (X467C) 82aa added at stop codon Long segment HSCR 15
M X467K 86aa added at stop codon Total colonic aganglionosis This study (patient 2)
NA: data not available from the reference.
*Hypoganglionosis was based on description cited in the reference.
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HMG domain and the transactivation domain
of the SOX10 protein is highly conserved
between the group E SOX proteins (96%
homology)22 and it could be involved in
protein-protein interaction,23 such that when
its structure is aVected by mutation it could
lead to more severe biochemical consequences.
Among the 12 cases reported, half of the
mutations are nonsense mutations resulting in
a truncation of the SOX10 polypeptide along
its length (table 2). The truncated mutant
mRNA produced by the mutant alleles could
be subjected to rapid decay because of the
mRNA surveillance mechanisms within the
cells,19 24 rendering a haploinsuYcient condi-
tion. In the case of the Y313X mutation,
varied mutant mRNA stability in the two
patients might account for the diVerent intes-
tinal phenotype observed.16 In view of the
structure of the SOX10 protein and its organ-
isation of functional domains, we postulate
that the WS4 features could be the result of a
dominant negative eVect of the mutant
protein, but not necessarily of haploinsuY-
ciency of normal SOX10. Particularly in those
cases where mutations of SOX10 occurred in
the C-terminal transactivation domain, the
mutant SOX10 protein could gain novel func-
tions and contribute to a more severe pheno-
type.
As also observed in other studies, there
remain a large number of Waardenburg-Shah
patients who do not have any SOX10 muta-
tions within the coding region and splice junc-
tions. Therefore, other mutations within the
SOX10 gene locus or other genes may be
responsible for their hypopigmentation and
intestinal aganglionosis phenotype. We also
found silent and polymorphic DNA changes in
the SOX10 gene of Hirschsprung’s disease
patients without Waardenburg syndrome
(Sham et al, unpublished data). Although these
nucleotide changes do not aVect the amino
acid sequence of SOX10 protein, given the
multigenic nature of Hirschsprung’s disease,
the importance of these silent and polymorphic
changes in the aetiology of Hirschsprung’s dis-
ease has yet to be evaluated.
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